Tissue Necrosis Following Diode Laser-assisted Transcanalicular Dacryocystorhinostomy

McClintic, Scott M.; Yoon, Michael K.; Bidar, Maziar; Dutton, Jonathan J.; Vagefi, M. Reza; Kersten, Robert C.

doi:10.1097/iop.0000000000000045

Cited by 9 publications

(8 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Third, the other benefits of laser-assisted DCR include less operating time, better cosmetic outcomes, less morbidity, and a shorter recovery time. 16 In our study of 27 DCRs, 89% of patients experienced long-term success. This is well within the expected success rate for all types of DCR and for endoscopic laser DCR as cited in the literature.…”

Section: Discussionmentioning

confidence: 61%

See 1 more Smart Citation

Dacryocystorhinostomy with a Thulium:YAG Laser—a Case Series

et al. 2018

View full text Add to dashboard Cite

We conducted a retrospective chart review of 27 patients—7 men and 20 women, aged 47 to 94 years (mean: 71.3)—with symptomatic epiphora secondary to dacryostenosis who had undergone thulium:YAG (Tm:YAG) laser dacryocystorhinostomy (DCR). Among them, dacryostenosis had been documented in 35 eyes by dacryocystography. The Tm:YAG procedure involved the administration of local anesthesia, after which a 600-μm laser fiber was inserted into the lacrimal canaliculi and then into the nasolacrimal duct. Under endoscopic visualization, the DCR was performed anterior and inferior to the middle turbinate, which created an opening. Silicone stents were then inserted and tied intranasally. In the immediate postoperative period, all 27 patients noted initial improvement. During a follow-up of 22 days to 25 months (mean: 11.3 mo), 24 of the 27 patients (89%) remained symptom-free, while the remaining 3 patients (11%) experienced a treatment failure and required revision surgery. To the best of our knowledge, only two articles on thulium laser therapy for DCR have been previously published, both approximately 25 years ago; both involved the use of a thulium along with holmium and chromium in cadavers. As far as we know, our case series is the largest in the English-language literature that has documented the use of the thulium in laser therapy for DCR, and it is the only in vivo study. We found that DCR with the Tm:YAG laser was an effective and affordable option for patients with symptomatic epiphora secondary to lacrimal obstruction.

show abstract

Section: Discussionmentioning

confidence: 61%

“…Several cases of tissue necrosis after diode-laserassisted DCR have been described in the literature. 16 Since our study involved Tm:YAG DCR, none of our patients developed such a complication.…”

Section: Discussionmentioning

confidence: 88%

Dacryocystorhinostomy with a Thulium:YAG Laser—a Case Series

et al. 2018

View full text Add to dashboard Cite

show abstract

“…Transcanalicular laser assisted DCR (TC-DCR) is a minimally invasive alternative to Ex DCR. 8,9 The obvious advantages of avoiding an external incision 10 and fast post-operative recovery made it attractive to many patients. 6 Short learning curve, less procedure time, 11 minimal per-operative bleeding during TC-DCR is gaining attention of ophthalmologists.…”

Section: Discussionmentioning

confidence: 99%

Transcanalicular diode laser assisted dacryocystorhinostomy: A breakthrough in the treatment of acquired nasolacrimal duct obstruction

et al. 2020

View full text Add to dashboard Cite

Objective: To evaluate the success rate of Transcanalicular Diode laser assisted Dacryocystorhinostomy (TC-DCR) in cases of acquired nasolacrimal duct obstruction (NLDO). Methods: This Quasi-Experimental study was conducted in Armed Forces Institute of Ophthalmology (AFIO) Rawalpindi, from July 2018 to April 2019. In this study, 73 patients of chronic dacryocystitis secondary to acquired NLDO were treated by TC-DCR under general anaesthesia. Follow up examination was done after one day, one week and three months. Silicone tubes were removed three months after surgery and syringing of lacrimal system done to confirm patency of lacrimal passages. Success of the procedure was documented as absence of epiphora and patent nasolacrimal duct on syringing. Results: Seventy three patients (males 27; females 46) were included in this study. Mean age of these patients was 51.6±21 years. On completion of this study which was three months after surgery, we found subjective improvement (absence of epiphora) in 86.3% patients and objective improvement (successful irrigation of lacrimal passages) in 93.2% patients. Conclusion: TC- DCR is a minimally invasive technique of doing Dacryocystorhinostomy and imparts more than 90% success rate. It has additional advantages of good cosmetic results, low complication rate and short surgery and convalescence time. doi: https://doi.org/10.12669/pjms.36.4.1906 How to cite this:Awais M, Naqvi SAH, Akram A, Shahid M. Transcanalicular diode laser assisted dacryocystorhinostomy: A breakthrough in the treatment of acquired nasolacrimal duct obstruction. Pak J Med Sci. 2020;36(4):---------. doi: https://doi.org/10.12669/pjms.36.4.1906 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

show abstract

“…Aksi takdirde mediyal kantusta ciddi cilt nekrozları ile karşılaşılabilmektedir. 30,31 Çalışmamızın zayıf yönü hasta sayısının az olmasıdır. Ancak, eksternal DSR cerrahisinin yüksek başarı oranı nedeni ile en az iki eksternal DSR geçirmiş ve nüks gelişmiş hasta sayısı düşük olduğu için çalışma bir olgu serisi olarak planlanmıştır.…”

Section: Discussionunclassified